CN105749181A - 一种治疗脂肪肝的中药组合物及其制备方法 - Google Patents
一种治疗脂肪肝的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN105749181A CN105749181A CN201610294414.9A CN201610294414A CN105749181A CN 105749181 A CN105749181 A CN 105749181A CN 201610294414 A CN201610294414 A CN 201610294414A CN 105749181 A CN105749181 A CN 105749181A
- Authority
- CN
- China
- Prior art keywords
- powder
- chinese medicine
- medicine composition
- quality
- dry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 206010019708 Hepatic steatosis Diseases 0.000 title claims abstract description 27
- 208000004930 Fatty Liver Diseases 0.000 title claims abstract description 24
- 231100000240 steatosis hepatitis Toxicity 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 210000000582 Semen Anatomy 0.000 claims abstract description 29
- 210000004369 Blood Anatomy 0.000 claims abstract description 26
- 239000008280 blood Substances 0.000 claims abstract description 26
- 240000005255 Rubus parvifolius Species 0.000 claims abstract description 15
- 235000018803 Rubus parvifolius Nutrition 0.000 claims abstract description 15
- 241001014715 Salvia kiaometiensis Species 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims description 59
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 235000019441 ethanol Nutrition 0.000 claims description 30
- 239000000706 filtrate Substances 0.000 claims description 30
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances data:image/svg+xml;base64,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 data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nODVweCcgaGVpZ2h0PSc4NXB4JyB2aWV3Qm94PScwIDAgODUgODUnPgo8IS0tIEVORCBPRiBIRUFERVIgLS0+CjxyZWN0IHN0eWxlPSdvcGFjaXR5OjEuMDtmaWxsOiNGRkZGRkY7c3Ryb2tlOm5vbmUnIHdpZHRoPSc4NS4wJyBoZWlnaHQ9Jzg1LjAnIHg9JzAuMCcgeT0nMC4wJz4gPC9yZWN0Pgo8dGV4dCB4PScxMy4zJyB5PSc1My42JyBjbGFzcz0nYXRvbS0wJyBzdHlsZT0nZm9udC1zaXplOjIzcHg7Zm9udC1zdHlsZTpub3JtYWw7Zm9udC13ZWlnaHQ6bm9ybWFsO2ZpbGwtb3BhY2l0eToxO3N0cm9rZTpub25lO2ZvbnQtZmFtaWx5OnNhbnMtc2VyaWY7dGV4dC1hbmNob3I6c3RhcnQ7ZmlsbDojRTg0MjM1JyA+SDwvdGV4dD4KPHRleHQgeD0nMjguMicgeT0nNjIuOScgY2xhc3M9J2F0b20tMCcgc3R5bGU9J2ZvbnQtc2l6ZToxNXB4O2ZvbnQtc3R5bGU6bm9ybWFsO2ZvbnQtd2VpZ2h0Om5vcm1hbDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6bm9uZTtmb250LWZhbWlseTpzYW5zLXNlcmlmO3RleHQtYW5jaG9yOnN0YXJ0O2ZpbGw6I0U4NDIzNScgPjI8L3RleHQ+Cjx0ZXh0IHg9JzM1LjAnIHk9JzUzLjYnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6MjNweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiNFODQyMzUnID5PPC90ZXh0Pgo8L3N2Zz4K O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 240000005428 Pistacia lentiscus Species 0.000 claims description 21
- 238000000605 extraction Methods 0.000 claims description 21
- 239000002775 capsule Substances 0.000 claims description 20
- 241000326575 Fuirena pubescens Species 0.000 claims description 14
- 241000233948 Typha Species 0.000 claims description 14
- 235000004224 Typha angustifolia Nutrition 0.000 claims description 14
- 235000005391 Typha capensis Nutrition 0.000 claims description 14
- 235000019026 Typha domingensis Nutrition 0.000 claims description 14
- 235000005324 Typha latifolia Nutrition 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='300px' height='300px' viewBox='0 0 300 300'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='300.0' height='300.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-1 atom-2' d='M 13.6,182.6 L 28.7,174.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-2 atom-3' d='M 28.7,174.3 L 43.5,183.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-3 atom-4' d='M 43.5,183.2 L 58.6,174.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-4 atom-5' d='M 58.6,174.8 L 73.4,183.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-5 atom-6' d='M 73.4,183.7 L 88.5,175.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-6 atom-7' d='M 88.5,175.3 L 103.3,184.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-7 atom-8' d='M 103.3,184.2 L 118.3,175.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-8 atom-9' d='M 118.3,175.9 L 133.1,184.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-9 atom-10' d='M 133.1,184.7 L 148.2,176.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-10 atom-11' d='M 148.2,176.4 L 163.0,185.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-11 atom-12' d='M 163.0,185.3 L 178.1,176.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-12 atom-13' d='M 178.1,176.9 L 192.9,185.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-13 atom-14' d='M 192.9,185.8 L 208.0,177.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-14 atom-15' d='M 208.0,177.4 L 222.8,186.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-15 atom-16' d='M 222.8,186.3 L 237.8,178.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-16 atom-17' d='M 237.8,178.0 L 252.6,186.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-17 atom-18' d='M 252.6,186.9 L 267.7,178.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-18 atom-19' d='M 267.7,178.5 L 272.4,181.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-18 atom-19' d='M 272.4,181.3 L 277.0,184.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-20' d='M 269.4,178.5 L 269.5,173.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-20' d='M 269.5,173.6 L 269.6,168.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-20' d='M 266.0,178.5 L 266.1,173.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-20' d='M 266.1,173.5 L 266.2,168.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-21 atom-22' d='M 13.6,145.0 L 28.7,136.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-22 atom-23' d='M 28.7,136.6 L 43.5,145.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-23 atom-24' d='M 43.5,145.5 L 58.6,137.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-24 atom-25' d='M 58.6,137.2 L 73.4,146.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23 atom-25 atom-26' d='M 73.4,146.1 L 88.5,137.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-24 atom-26 atom-27' d='M 88.5,137.7 L 103.3,146.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-25 atom-27 atom-28' d='M 103.3,146.6 L 118.3,138.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-26 atom-28 atom-29' d='M 118.3,138.2 L 133.1,147.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-27 atom-29 atom-30' d='M 133.1,147.1 L 148.2,138.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-28 atom-30 atom-31' d='M 148.2,138.8 L 163.0,147.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-29 atom-31 atom-32' d='M 163.0,147.6 L 178.1,139.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-30 atom-32 atom-33' d='M 178.1,139.3 L 192.9,148.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-31 atom-33 atom-34' d='M 192.9,148.2 L 208.0,139.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-32 atom-34 atom-35' d='M 208.0,139.8 L 222.8,148.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-33 atom-35 atom-36' d='M 222.8,148.7 L 237.8,140.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-34 atom-36 atom-37' d='M 237.8,140.3 L 252.6,149.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-35 atom-37 atom-38' d='M 252.6,149.2 L 267.7,140.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-36 atom-38 atom-39' d='M 267.7,140.9 L 272.4,143.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-36 atom-38 atom-39' d='M 272.4,143.7 L 277.0,146.5' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-37 atom-38 atom-40' d='M 269.4,140.9 L 269.5,135.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-37 atom-38 atom-40' d='M 269.5,135.9 L 269.6,131.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-37 atom-38 atom-40' d='M 266.0,140.8 L 266.1,135.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-37 atom-38 atom-40' d='M 266.1,135.9 L 266.2,130.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='152.1' y='115.6' class='atom-0' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#3B4143' >M</text>
<text x='156.8' y='115.6' class='atom-0' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#3B4143' >g</text>
<text x='160.0' y='112.8' class='atom-0' style='font-size:4px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#3B4143' >2</text>
<text x='161.9' y='112.8' class='atom-0' style='font-size:4px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#3B4143' >+</text>
<text x='280.4' y='190.8' class='atom-19' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='285.2' y='188.1' class='atom-19' style='font-size:4px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='266.0' y='164.7' class='atom-20' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='280.4' y='153.2' class='atom-39' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='285.2' y='150.4' class='atom-39' style='font-size:4px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='266.0' y='127.1' class='atom-40' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='85px' height='85px' viewBox='0 0 85 85'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='85.0' height='85.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-1 atom-2' d='M 3.4,50.9 L 7.5,48.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-2 atom-3' d='M 7.5,48.6 L 11.6,51.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-3 atom-4' d='M 11.6,51.0 L 15.8,48.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-4 atom-5' d='M 15.8,48.7 L 19.9,51.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-5 atom-6' d='M 19.9,51.2 L 24.0,48.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-6 atom-7' d='M 24.0,48.9 L 28.1,51.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-7 atom-8' d='M 28.1,51.3 L 32.3,49.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-8 atom-9' d='M 32.3,49.0 L 36.4,51.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-9 atom-10' d='M 36.4,51.5 L 40.5,49.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-10 atom-11' d='M 40.5,49.2 L 44.6,51.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-11 atom-12' d='M 44.6,51.6 L 48.8,49.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-12 atom-13' d='M 48.8,49.3 L 52.8,51.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-13 atom-14' d='M 52.8,51.8 L 57.0,49.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-14 atom-15' d='M 57.0,49.4 L 61.1,51.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-15 atom-16' d='M 61.1,51.9 L 65.3,49.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-16 atom-17' d='M 65.3,49.6 L 69.3,52.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-17 atom-18' d='M 69.3,52.0 L 73.5,49.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-18 atom-19' d='M 73.5,49.7 L 74.6,50.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-18 atom-19' d='M 74.6,50.4 L 75.7,51.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-20' d='M 74.0,49.7 L 74.0,48.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-20' d='M 74.0,48.9 L 74.0,48.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-20' d='M 73.0,49.7 L 73.0,48.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-20' d='M 73.0,48.9 L 73.1,48.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-21 atom-22' d='M 3.4,40.5 L 7.5,38.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-22 atom-23' d='M 7.5,38.2 L 11.6,40.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-23 atom-24' d='M 11.6,40.6 L 15.8,38.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-24 atom-25' d='M 15.8,38.3 L 19.9,40.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23 atom-25 atom-26' d='M 19.9,40.8 L 24.0,38.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-24 atom-26 atom-27' d='M 24.0,38.5 L 28.1,40.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-25 atom-27 atom-28' d='M 28.1,40.9 L 32.3,38.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-26 atom-28 atom-29' d='M 32.3,38.6 L 36.4,41.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-27 atom-29 atom-30' d='M 36.4,41.1 L 40.5,38.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-28 atom-30 atom-31' d='M 40.5,38.8 L 44.6,41.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-29 atom-31 atom-32' d='M 44.6,41.2 L 48.8,38.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-30 atom-32 atom-33' d='M 48.8,38.9 L 52.8,41.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-31 atom-33 atom-34' d='M 52.8,41.4 L 57.0,39.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-32 atom-34 atom-35' d='M 57.0,39.1 L 61.1,41.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-33 atom-35 atom-36' d='M 61.1,41.5 L 65.3,39.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-34 atom-36 atom-37' d='M 65.3,39.2 L 69.3,41.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-35 atom-37 atom-38' d='M 69.3,41.7 L 73.5,39.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-36 atom-38 atom-39' d='M 73.5,39.4 L 74.6,40.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-36 atom-38 atom-39' d='M 74.6,40.0 L 75.7,40.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-37 atom-38 atom-40' d='M 74.0,39.4 L 74.0,38.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-37 atom-38 atom-40' d='M 74.0,38.5 L 74.0,37.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-37 atom-38 atom-40' d='M 73.0,39.3 L 73.0,38.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-37 atom-38 atom-40' d='M 73.0,38.5 L 73.1,37.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='40.4' y='34.4' class='atom-0' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#3B4143' >M</text>
<text x='44.5' y='34.4' class='atom-0' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#3B4143' >g</text>
<text x='47.3' y='32.0' class='atom-0' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#3B4143' >2</text>
<text x='48.9' y='32.0' class='atom-0' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#3B4143' >+</text>
<text x='75.8' y='55.2' class='atom-19' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='79.9' y='52.8' class='atom-19' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='71.8' y='48.0' class='atom-20' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='75.8' y='44.8' class='atom-39' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='79.9' y='42.4' class='atom-39' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='71.8' y='37.6' class='atom-40' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 9
- 239000007924 injection Substances 0.000 claims description 9
- 238000002347 injection Methods 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nMzAwcHgnIGhlaWdodD0nMzAwcHgnIHZpZXdCb3g9JzAgMCAzMDAgMzAwJz4KPCEtLSBFTkQgT0YgSEVBREVSIC0tPgo8cmVjdCBzdHlsZT0nb3BhY2l0eToxLjA7ZmlsbDojRkZGRkZGO3N0cm9rZTpub25lJyB3aWR0aD0nMzAwLjAnIGhlaWdodD0nMzAwLjAnIHg9JzAuMCcgeT0nMC4wJz4gPC9yZWN0Pgo8dGV4dCB4PSczOC43JyB5PScxNzAuMCcgY2xhc3M9J2F0b20tMCcgc3R5bGU9J2ZvbnQtc2l6ZTo0MHB4O2ZvbnQtc3R5bGU6bm9ybWFsO2ZvbnQtd2VpZ2h0Om5vcm1hbDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6bm9uZTtmb250LWZhbWlseTpzYW5zLXNlcmlmO3RleHQtYW5jaG9yOnN0YXJ0O2ZpbGw6I0U4NDIzNScgPkg8L3RleHQ+Cjx0ZXh0IHg9JzY0LjMnIHk9JzE3MC4wJyBjbGFzcz0nYXRvbS0wJyBzdHlsZT0nZm9udC1zaXplOjQwcHg7Zm9udC1zdHlsZTpub3JtYWw7Zm9udC13ZWlnaHQ6bm9ybWFsO2ZpbGwtb3BhY2l0eToxO3N0cm9rZTpub25lO2ZvbnQtZmFtaWx5OnNhbnMtc2VyaWY7dGV4dC1hbmNob3I6c3RhcnQ7ZmlsbDojRTg0MjM1JyA+TzwvdGV4dD4KPHRleHQgeD0nOTEuOScgeT0nMTU0LjAnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6MjZweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiNFODQyMzUnID4tPC90ZXh0Pgo8dGV4dCB4PScyMDAuNycgeT0nMTcwLjAnIGNsYXNzPSdhdG9tLTEnIHN0eWxlPSdmb250LXNpemU6NDBweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiMzQjQxNDMnID5OPC90ZXh0Pgo8dGV4dCB4PScyMjguMycgeT0nMTcwLjAnIGNsYXNzPSdhdG9tLTEnIHN0eWxlPSdmb250LXNpemU6NDBweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiMzQjQxNDMnID5hPC90ZXh0Pgo8dGV4dCB4PScyNDkuNicgeT0nMTU0LjAnIGNsYXNzPSdhdG9tLTEnIHN0eWxlPSdmb250LXNpemU6MjZweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiMzQjQxNDMnID4rPC90ZXh0Pgo8L3N2Zz4K data:image/svg+xml;base64,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 [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 8
- 244000150668 Zea mays subsp mays Species 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 6
- 238000004090 dissolution Methods 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 235000019359 magnesium stearate Nutrition 0.000 claims description 6
- 239000008188 pellet Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 230000003068 static Effects 0.000 claims description 6
- 239000004952 Polyamide Substances 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000005202 decontamination Methods 0.000 claims description 3
- 230000003588 decontaminative Effects 0.000 claims description 3
- 238000005453 pelletization Methods 0.000 claims description 3
- 229920002647 polyamide Polymers 0.000 claims description 3
- 239000011528 polyamide (building material) Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 230000001954 sterilising Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000008215 water for injection Substances 0.000 claims description 3
- 239000008298 dragée Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- -1 sublimed preparation Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 210000004185 Liver Anatomy 0.000 abstract description 14
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 210000000952 Spleen Anatomy 0.000 abstract description 6
- 230000003908 liver function Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000003213 activating Effects 0.000 abstract description 2
- 241001573366 Astragalus membranaceus Species 0.000 abstract 1
- 240000004385 Centaurea cyanus Species 0.000 abstract 1
- 235000005940 Centaurea cyanus Nutrition 0.000 abstract 1
- 240000004499 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 241000208689 Eucommia ulmoides Species 0.000 abstract 1
- 241001553700 Euphorbia lathyris Species 0.000 abstract 1
- 241001343709 Iris dichotoma Species 0.000 abstract 1
- 241001574635 Scutellaria yunnanensis Species 0.000 abstract 1
- 241000331449 Vincetoxicum pycnostelma Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 231100000486 side effect Toxicity 0.000 abstract 1
- 210000000214 Mouth Anatomy 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 230000001737 promoting Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 5
- 208000006454 Hepatitis Diseases 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 201000004624 dermatitis Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 231100000283 hepatitis Toxicity 0.000 description 4
- 230000002522 swelling Effects 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010019842 Hepatomegaly Diseases 0.000 description 3
- 206010019847 Hepatosplenomegaly Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 210000003734 Kidney Anatomy 0.000 description 3
- 231100000111 LD50 Toxicity 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 231100000614 Poison Toxicity 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 201000000736 amenorrhea Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 230000025627 positive regulation of urine volume Effects 0.000 description 3
- 230000001225 therapeutic Effects 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 210000004204 Blood Vessels Anatomy 0.000 description 2
- 206010061428 Decreased appetite Diseases 0.000 description 2
- 206010012601 Diabetes mellitus Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000001848 Dysentery Diseases 0.000 description 2
- 208000005679 Eczema Diseases 0.000 description 2
- 210000003026 Hypopharynx Anatomy 0.000 description 2
- 206010022114 Injury Diseases 0.000 description 2
- 206010027327 Menstrual disease Diseases 0.000 description 2
- 210000004915 Pus Anatomy 0.000 description 2
- 206010072736 Rheumatic disease Diseases 0.000 description 2
- 206010040490 Sexually transmitted disease Diseases 0.000 description 2
- 210000002784 Stomach Anatomy 0.000 description 2
- 230000003187 abdominal Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 230000000994 depressed Effects 0.000 description 2
- 231100000406 dermatitis Toxicity 0.000 description 2
- 201000009910 diseases by infectious agent Diseases 0.000 description 2
- 229940079593 drugs Drugs 0.000 description 2
- 231100001003 eczema Toxicity 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000002440 hepatic Effects 0.000 description 2
- 230000003054 hormonal Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 238000009527 percussion Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000000552 rheumatic Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000002485 urinary Effects 0.000 description 2
- 210000001015 Abdomen Anatomy 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 210000004404 Adrenal Cortex Anatomy 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000006673 Asthma Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 210000001185 Bone Marrow Anatomy 0.000 description 1
- 210000000481 Breast Anatomy 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 210000003169 Central Nervous System Anatomy 0.000 description 1
- 230000037242 Cmax Effects 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000002173 Dizziness Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010016173 Fall Diseases 0.000 description 1
- 206010016256 Fatigue Diseases 0.000 description 1
- 102100004383 GZMA Human genes 0.000 description 1
- 101710014159 GZMA Proteins 0.000 description 1
- 210000000232 Gallbladder Anatomy 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010018836 Haematochezia Diseases 0.000 description 1
- 206010019233 Headache Diseases 0.000 description 1
- 210000003494 Hepatocytes Anatomy 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 210000000987 Immune System Anatomy 0.000 description 1
- 206010022437 Insomnia Diseases 0.000 description 1
- 210000003127 Knee Anatomy 0.000 description 1
- 206010024378 Leukocytosis Diseases 0.000 description 1
- 206010024379 Leukocytosis Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 210000004072 Lung Anatomy 0.000 description 1
- 208000004396 Mastitis Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 231100000643 Substance intoxication Toxicity 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 210000001138 Tears Anatomy 0.000 description 1
- 206010044008 Tonsillitis Diseases 0.000 description 1
- 208000004371 Toothache Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 210000002700 Urine Anatomy 0.000 description 1
- 206010046736 Urticarias Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 201000009030 carcinoma Diseases 0.000 description 1
- 210000004027 cells Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary Effects 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000020828 fasting Nutrition 0.000 description 1
- 230000032686 female pregnancy Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001976 improved Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 101710031899 moon Proteins 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000003000 nontoxic Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000001817 pituitary Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000001047 pyretic Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory Effects 0.000 description 1
- 230000003014 reinforcing Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002269 spontaneous Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Abstract
本发明公开了一种治疗脂肪肝的中药组合物,其包括:血沟丹、茅莓、土丹参、莪术、扁蒲扇、千金子、决明子、玉米花、徐长卿、杜仲、黄芪,本发明还公开了上述中药组合物的制备方法。采用此种中药组合物能够防治肝脏脂肪变性、保护肝功能,无毒副作用,能活血祛瘀、健脾养肝、祛湿养阴,标本兼治,保证血脉运行畅通,减少脂肪肝的复发几率。
Description
技术领域
[0001] 本发明设及一种医用配制品,尤其设及一种用于治疗脂肪肝的中药组合物及其制 备方法。
背景技术
[0002] 脂肪肝是由多种原因引起的肝脏脂肪性病变,当肝细胞内脂质蓄积超过5%,或组 织学上,每单位面积Ξ分之一 W上肝细胞脂变时称为脂肪肝。脂肪肝发病机理至今尚未明 确,现代医学认为可能与多种因素有关,如脂质代谢异常、激素水平改变、环境和遗传因素、 脂质过氧化损害、免疫反应、缺氧和肝循环障碍等在其发病中起一定的作用。近年来由于生 活习惯、饮食结构等多种因素的影响,我国脂肪肝发病有逐渐增加的趋势,肥胖症、药物及 药物中毒、糖尿病、妊娠、肝炎病毒或其他病原体感染等都可W引起脂肪肝的发生。
[0003] 中医治疗脂肪肝W疏肝理气、化疲桂疲、疏肝健脾、桂湿化疲、滋肾养肝、活血化 疲、清热化疲、益气活血、消肿散结等为原则。由于中医治疗脂肪肝,疗效好,无副作用,深受 患者欢迎。
发明内容
[0004] 为了解决上述问题,本发明提供一种能够防治肝脏脂肪变性、保护肝功能、无毒副 作用、活血桂疲、健脾养肝、桂湿养阴、标本兼治、保证血脉运行杨通、减少脂肪肝的复发几 率的治疗脂肪肝的中药组合物。
[0005] 本发明采用的技术方案是:一种治疗脂肪肝的中药组合物,所述中药组合物的各 组份为血沟丹、茅替、±丹参、義术、扁蒲扇、千金子、决明子、玉米花、徐长卿、杜仲、黄巧。
[0006] 优选的,各种组份的重量份数比为血沟丹25-35份、茅替15-25份、±丹参15-25份、 義术10-20份、扁蒲扇10-20份、千金子5-15份、决明子5-15份、玉米花5-15份、徐长卿5-15 份、杜仲5-15份、黄巧5-15份。
[0007] 更优选的,各种组份的重量份数比为血沟丹30-35份、茅替20-25份、±丹参20-25 份、義术10-15份、扁蒲扇10-15份、千金子5-10份、决明子5-10份、玉米花5-10份、徐长卿δ¬ ιό份 、杜仲 5-10份 、黄巧 5-10份。
[000引其中,所述中药组合物的剂型为:薄膜衣片剂、丹剂、硬膏剂、糖浆剂、口服液、口含 剂、颗粒剂、散剂、注射剂、糖衣片剂、胶囊剂。
[0009] 本发明还提供了上述中药组合物的制备方法,当所述中药的剂型为胶囊剂时,包 括:
[0010] 第一步,茅替、上丹参按比例混合,用相当于混合物质量2-3倍的醇浓度为70-80% 的正丙醇回流提取2-4次,合并滤液,减压浓缩、干燥并粉碎成粉末,随后用乙醇提纯1-2次, 合并提取液,减压回收乙醇并浓缩至60°C下相对密度为1.21-1.24的膏体,干燥并粉碎成粉 末;
[0011] 第二步,将義术、扁蒲扇、千金子、决明子用醇浓度为80-90%的正丙醇提取2-3次, 合并提取液,减压浓缩并进行干燥、粉碎成粉末,将粉碎后的粉末加入相对于其质量为2-4 倍量的水溶解,静止1-3小时,过滤,滤液减压浓缩为60°C下相对密度为1.21-1.24的膏体并 干燥,粉碎成粉末;
[001^ 第;步,将余下组份研成粉末按比例混合,加水煎煮2次,每次2-3小时,分别过滤, 合并滤液,滤液浓缩成膏体并干燥,粉碎成粉末,所加入的水的质量为第Ξ步的混合物质量 的2-4倍;
[0013] 第四步,将上述粉末和淀粉混合,随后进行制粒处理并干燥,得到混合物颗粒,再 向混合物颗粒中加入硬脂酸儀,所述硬脂酸儀和所述混合物颗粒质量之比为0.25-100; 0.5-100,获得胶囊内容物,将所述的胶囊内容物装入胶囊壳体中即得胶囊剂。
[0014] 本发明还提供了上述中药组合物的制备方法,当所述中药的剂型为注射剂时,包 括:
[0015] 第一步,茅替、±丹参按比例混合,用相当于混合物质量2-3倍的醇浓度为70-80% 的正丙醇回流提取2-4次,合并滤液,减压浓缩、干燥并粉碎成粉末,随后用乙醇提纯1-2次, 合并提取液,减压回收乙醇并浓缩至60°C下相对密度为1.21-1.24的膏体,干燥并粉碎成粉 末;
[0016] 第二步,将義术、扁蒲扇、千金子、决明子用醇浓度为80-90%的正丙醇提取2-3次, 合并提取液,减压浓缩并进行干燥、粉碎成粉末,将粉碎后的粉末加入相对于其质量为2-4 倍量的水溶解,静止1-3小时,过滤,滤液减压浓缩为60°C下相对密度为1.21-1.24的膏体并 干燥,粉碎成粉末;
[0017]第Ξ步,将余下组份研成粉末按比例混合,加水煎煮2次,每次2-3小时,分别过滤, 合并滤液,滤液浓缩成膏体并干燥,粉碎成粉末,所加入的水的质量为第Ξ步的混合物质量 的2-4倍;
[0018] 第四步,将上述粉末混合,随后将其溶于质量为混合物2-4倍的水,揽拌下加入相 对于粉末质量5%-15%的氨氧化钢助溶,过滤,加浓度为Imol/L的盐酸调节抑值为5-6,过 滤,沉淀备用,滤液通过聚酷胺柱,先用水洗去杂质,随后用醇浓度为80-90%的正丙醇洗 脱,收集正丙醇洗脱液,沉淀用醇浓度为80-90%的正丙醇提取2次,过滤,滤液与上述洗脱 液合并,回收正丙醇,减压浓缩至膏体并喷雾干燥成粉末,将获得的粉末加相对于其质量1- 2倍的氯化钢及注射用水适量,溶解后再进一步加注射用水至需要的体积,过滤,灌封,灭 菌,获得需要的注射液。
[0019] 血沟丹,味苦,性寒,清热泻火;化疲解毒。主高热不退;肺热咳喘;热毒泻频;肝脾 肿大。
[0020] 茅替,味苦、涩,性凉,清热凉血,散结,止痛,利尿消肿。用于感冒发热,咽喉肿痛, 咯血,吐血,频疾,肠炎,肝炎,肝脾肿大,肾炎水肿,泌尿系感染,结石,月经不调,白带,风湿 骨痛,跌打肿痛;外用治湿疹,皮炎。
[0021] ±丹参,味苦、性微寒,活血调经;化疲止痛。主月经不调;痛经;经闭;产后疲阴腹 痛;肝脾肿大;关节痛;胸绞痛;屯、惇;失眠。
[0022] 義术,味辛、苦,性溫,归肝、脾经,行气破血,消积止痛。用于輝瘤瘡块,疲血经闭, 食积胀痛;早期宫颈癌。
[0023] 千金子,味辛、溫,归肝、肾、大肠经,逐水消肿,破血消症。用于水肿,疲饮,积滞胀 满,二便不通,血疲经闭;外治顽癖,痛寶。
[0024]扁蒲扇,味苦、寒,有小毒,清热解毒,活血消肿。主治咽喉肿痛,扁桃体炎,肝炎,肝 肿大,胃痛,乳腺炎。
[002引决明子,味甘、苦、咸,微寒,归肝、大肠经,清热明目,润肠通便。用于目赤涩痛,羞 明多泪,头痛眩晕,目暗不明,大便秘结。
[00%]玉米花,味甘、性凉,疏肝利胆。主肝炎;胆囊炎。
[0027]徐长卿,味辛,性溫,归肝、胃经,桂风化湿,止痛止痒。用于风湿搏痛,胃痛胀满,牙 痛,腰痛,跌扑损伤,等麻疹、湿疹。
[002引杜仲,味辛、甘,性溫,无毒,杜仲具有补肝肾,治腰脊酸疼,足膝瘦弱,小便余渐,阴 下湿痒,高血压、安胎的功效。
[0029] 杜仲对免疫系统、内分泌系统、中枢神经系统、循环系统和泌尿系统都有不同程度 的调节作用,杜仲能兴奋垂体-肾上腺皮质系统,增强肾上腺皮质功能。
[0030] 黄巧,味甘、性溫,归肺、脾经,补气固表,利尿托毒,排脈,敛疮生肌。用于气虚乏 力,食少便漉,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,痴痘难溃,久溃不敛,血 虚瘦黄,内热消渴;慢性肾炎蛋白尿,糖尿病。
[0031] 本发明的有益效果:
[0032] 相对于现有技术中的具有治疗脂肪肝效果的药物,采用此种中药组合物能够防治 肝脏脂肪变性、保护肝功能,无毒副作用,能活血桂疲、健脾养肝、桂湿养阴,标本兼治,保证 血脉运行杨通,减少脂肪肝的复发几率。
具体实施方式
[0033] 实施例1:
[0034] ( - )一种治疗脂肪肝的中药,由W下原料药按重量份配比而成:
[0035] 血沟丹30份、茅替25份、±丹参20份、義术15份、扁蒲扇15份、千金子10份、决明子 10份、玉米花10份、徐长卿10份、杜仲5份、黄巧5份。
[003引(二)制备方法:
[0037] 第一步,茅替、±丹参按比例混合,用相当于混合物质量2倍的醇浓度为70%的正 丙醇回流提取2次,合并滤液,减压浓缩、干燥并粉碎成粉末,随后用乙醇提纯1-2次,合并提 取液,减压回收乙醇并浓缩至60°C下相对密度为1.21-1.24的膏体,干燥并粉碎成粉末;
[0038] 第二步,将義术、扁蒲扇、千金子、决明子用醇浓度为80-90%的正丙醇提取2-3次, 合并提取液,减压浓缩并进行干燥、粉碎成粉末,将粉碎后的粉末加入相对于其质量为2倍 量的水溶解,静止1小时,过滤,滤液减压浓缩为60°C下相对密度为1.21-1.24的膏体并干 燥,粉碎成粉末;
[0039] 第Ξ步,将余下组份研成粉末按比例混合,加水煎煮2次,每次2小时,分别过滤,合 并滤液,滤液浓缩成膏体并干燥,粉碎成粉末,所加入的水的质量为第Ξ步的混合物质量的 2倍;
[0040] 第四步,将上述粉末和淀粉混合,随后进行制粒处理并干燥,得到混合物颗粒,再 向混合物颗粒中加入硬脂酸儀,所述硬脂酸儀和所述混合物颗粒质量之比为0.25:0.5,获 得胶囊内容物,将所述的胶囊内容物装入胶囊壳体中即得胶囊剂。
[0041 ] 实施例2:
[0042] ( - )一种治疗脂肪肝的中药,由W下原料药按重量份配比而成:同实施例1。
[0043] (二)制备方法:
[0044] 第一步,茅替、±丹参按比例混合,用相当于混合物质量2倍的醇浓度为70%的正 丙醇回流提取2次,合并滤液,减压浓缩、干燥并粉碎成粉末,随后用乙醇提纯1次,合并提取 液,减压回收乙醇并浓缩至60°C下相对密度为1.21-1.24的膏体,干燥并粉碎成粉末;
[0045] 第二步,将義术、扁蒲扇、千金子、决明子用醇浓度为80%的正丙醇提取2次,合并 提取液,减压浓缩并进行干燥、粉碎成粉末,将粉碎后的粉末加入相对于其质量为2倍量的 水溶解,静止1小时,过滤,滤液减压浓缩为60°C下相对密度为1.21-1.24的膏体并干燥,粉 碎成粉末;
[0046] 第Ξ步,将余下组份研成粉末按比例混合,加水煎煮2次,每次2小时,分别过滤,合 并滤液,滤液浓缩成膏体并干燥,粉碎成粉末,所加入的水的质量为第Ξ步的混合物质量的 2倍;
[0047] 第四步,将上述粉末混合,随后将其溶于质量为混合物2倍的水,揽拌下加入相对 于粉末质量5%的氨氧化钢助溶,过滤,加浓度为Imol/L的盐酸调节pH值为5-6,过滤,沉淀 备用,滤液通过聚酷胺柱,先用水洗去杂质,随后用醇浓度为80的正丙醇洗脱,收集正丙醇 洗脱液,沉淀用醇浓度为80的正丙醇提取2次,过滤,滤液与上述洗脱液合并,回收正丙醇, 减压浓缩至膏体并喷雾干燥成粉末,将获得的粉末加相对于其质量2倍的氯化钢及注射用 水适量,溶解后再进一步加注射用水至需要的体积,过滤,灌封,灭菌,获得需要的注射液。 [004引实施例3:
[0049] 1、长期毒性试验过程:
[0050] 应用Wistar大鼠(北京维通利华实验动物技术有限公司提供)将实验药物设定为 高、中、低Ξ个剂量,分别为实施例1配方的胶囊剂8邑/4邑、4邑/4邑、2邑/1^。按人用剂量0.1邑/ kg/天片计算,分别为人用有效剂量的80倍、40倍和20倍;另设一对照组,连续灌胃给药90 天、180天和部分动物停药10天后,观察对大鼠各项生理、生化指标的影响。实验结果表明: 用不同剂量给大鼠连续口服180天,对大鼠的进食量和体重增长均无影响。对肝肾功能均未 发现明显毒性作用。对血常规、血生化、尿液生化及骨髓片等均未见明显影响,各组间与对 照组比较无明显差异。
[0051 ] 2、急性毒性试验过程:
[0052]应用ICR小鼠(北京维通利华实验动物技术有限公司提供)40只,体重在25-30克, 进行急性毒性实验。小鼠随机分为两组,即对照组、给药组,实验前禁食12小时,然后给予如 实施例1制备得到的本发明的中药胶囊剂混悬液(将胶囊剂溶解在水中获得混悬液)灌胃, 对给药的半数致死量化化0)进行了试验测定,但未测到LDso,因此进行了最大耐受量试验。 结果:W最大浓度(60%),最大给药量(120ml/kg,一日内份四次给完)100g/kg灌胃,相当于 生药量60g/kg,相当于成人临床拟日用剂量的300倍(按75kg),屯日内小鼠无一死亡,处死 小鼠解剖观察各脏器未发现毒性反应,给药组与对照组小鼠无任何差异。
[0化3] 实施例4:
[0054] 本发明的临床治疗观察如下:
[0055] (一)患者300例,其中150例为女性、150例为男性。
[0化6](二)诊断标准;
[0057] 诊断标准:《中医内科病证诊断疗效标准》确定诊断标准:
[0058] 1)食欲不振、腹胀、疲倦乏力、发热、恶屯、、呕吐、体重减轻;
[0059] 2)右上腹压痛或叩击痛;
[0060] 3)肝脏轻度肿大有触痛,伴有脾肿大和肝掌;
[0061] 4)白细胞增多等其他脂肪肝症状。
[0062] (立)治疗方法:1组:采用如实施例1制备方法制得的胶囊剂lOOg,分成10份,每天 早晨空腹服用一份,30天为一个疗程,连续服用Ξ个疗程;2组:采用如实施例2制备方法制 得的注射剂lOOg,分成10份,每天早晨空腹注射一份,30天为一个疗程,连续注射Ξ个疗程; 另设一对照组。
[0063] (四)疗效评定标准:
[0064] 疗效标准:
[0065] 整体疗效评定参照《中药新药临床研究指导原则》相关标准:
[0066] 治愈:主要症状消失,肝肿大消失或回缩,肝区无明显压痛或叩击痛,肝功能正常, 超声回声图及声像图正常,血脂趋于正常或明显改善,体重下降;
[0067] 有效:主要症状基本消失,肝肿大有所恢复,超声图像明显好转,血脂有所改善,体 重有所下降;
[0068] 无效:症状、体征、化验、超声图像及体重无改变。
[0069] (五)治疗结果见表1:
[0070] 表1治疗结果
[0071]
[0072] 上述实施例只是为了说明本发明的技术构思及特点,其目的是在于让本领域内的 普通技术人员能够了解本发明的内容并据W实施,并不能W此限制本发明的保护范围。凡 是根据本发明内容的实质所作出的等效的变化或修饰,都应涵盖在本发明的保护范围。
Claims (6)
1. 一种治疗脂肪肝的中药组合物,其特征在于:所述中药组合物的各组份为血沟丹、茅 莓、土丹参、莪术、扁蒲扇、千金子、决明子、玉米花、徐长卿、杜仲、黄芪。。
2. 如权利要求1所述的中药组合物,其特征在于:各种组份的重量份数比为血沟丹25-35份、茅莓15-25份、土丹参15-25份、莪术10-20份、扁蒲扇10-20份、千金子5-15份、决明子 5-15份、玉米花5-15份、徐长卿5-15份、杜仲5-15份、黄芪5-15份。
3. 如权利要求1所述的中药组合物,其特征在于:各种组份的重量份数比为血沟丹30-35份、茅莓20-25份、土丹参20-25份、莪术10-15份、扁蒲扇10-15份、千金子5-10份、决明子 5-10份、玉米花5-10份、徐长卿5-10份、杜仲5-10份、黄芪5-10份。
4. 如权利要求1-3中任一项所述治疗脂肪肝的中药组合物,其特征在于,所述中药组合 物的剂型为:薄膜衣片剂、丹剂、硬膏剂、糖浆剂、口服液、口含剂、颗粒剂、散剂、注射剂、糖 衣片剂、胶囊剂。
5. -种如权利要求1-3中任一项所述治疗脂肪肝的中药组合物的制备方法,其特征在 于:当所述中药的剂型为胶囊剂时,包括: 第一步,茅莓、土丹参按比例混合,用相当于混合物质量2-3倍的醇浓度为70-80%的正 丙醇回流提取2-4次,合并滤液,减压浓缩、干燥并粉碎成粉末,随后用乙醇提纯1-2次,合并 提取液,减压回收乙醇并浓缩至60°C下相对密度为1.21-1.24的膏体,干燥并粉碎成粉末; 第二步,将莪术、扁蒲扇、千金子、决明子用醇浓度为80-90%的正丙醇提取2-3次,合并 提取液,减压浓缩并进行干燥、粉碎成粉末,将粉碎后的粉末加入相对于其质量为2-4倍量 的水溶解,静止1-3小时,过滤,滤液减压浓缩为60°C下相对密度为1.21-1.24的膏体并干 燥,粉碎成粉末; 第三步,将余下组份研成粉末按比例混合,加水煎煮2次,每次2-3小时,分别过滤,合并 滤液,滤液浓缩成膏体并干燥,粉碎成粉末,所加入的水的质量为第三步的混合物质量的2-4倍; 第四步,将上述粉末和淀粉混合,随后进行制粒处理并干燥,得到混合物颗粒,再向混 合物颗粒中加入硬脂酸镁,所述硬脂酸镁和所述混合物颗粒质量之比为〇 . 25-100 : 0.5-1 〇〇,获得胶囊内容物,将所述的胶囊内容物装入胶囊壳体中即得胶囊剂。
6. -种如权利要求1-3中任一项所述治疗脂肪肝的中药组合物的制备方法,其特征在 于:当所述中药的剂型为注射剂时,包括: 第一步,茅莓、土丹参按比例混合,用相当于混合物质量2-3倍的醇浓度为70-80%的正 丙醇回流提取2-4次,合并滤液,减压浓缩、干燥并粉碎成粉末,随后用乙醇提纯1-2次,合并 提取液,减压回收乙醇并浓缩至60°C下相对密度为1.21-1.24的膏体,干燥并粉碎成粉末; 第二步,将莪术、扁蒲扇、千金子、决明子用醇浓度为80-90%的正丙醇提取2-3次,合并 提取液,减压浓缩并进行干燥、粉碎成粉末,将粉碎后的粉末加入相对于其质量为2-4倍量 的水溶解,静止1-3小时,过滤,滤液减压浓缩为60°C下相对密度为1.21-1.24的膏体并干 燥,粉碎成粉末; 第三步,将余下组份研成粉末按比例混合,加水煎煮2次,每次2-3小时,分别过滤,合并 滤液,滤液浓缩成膏体并干燥,粉碎成粉末,所加入的水的质量为第三步的混合物质量的2-4倍; 第四步,将上述粉末混合,随后将其溶于质量为混合物2-4倍的水,搅拌下加入相对于 粉末质量5 % -15 %的氢氧化钠助溶,过滤,加浓度为lmol/L的盐酸调节pH值为5-6,过滤,沉 淀备用,滤液通过聚酰胺柱,先用水洗去杂质,随后用醇浓度为80-90 %的正丙醇洗脱,收集 正丙醇洗脱液,沉淀用醇浓度为80-90 %的正丙醇提取2次,过滤,滤液与上述洗脱液合并, 回收正丙醇,减压浓缩至膏体并喷雾干燥成粉末,将获得的粉末加相对于其质量1-2倍的氯 化钠及注射用水适量,溶解后再进一步加注射用水至需要的体积,过滤,灌封,灭菌,获得需 要的注射液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610294414.9A CN105749181A (zh) | 2016-04-29 | 2016-04-29 | 一种治疗脂肪肝的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610294414.9A CN105749181A (zh) | 2016-04-29 | 2016-04-29 | 一种治疗脂肪肝的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105749181A true CN105749181A (zh) | 2016-07-13 |
Family
ID=56322697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610294414.9A Withdrawn CN105749181A (zh) | 2016-04-29 | 2016-04-29 | 一种治疗脂肪肝的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105749181A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106334046A (zh) * | 2016-08-04 | 2017-01-18 | 青岛友诚高新技术有限公司 | 一种治疗鼻炎的中药组合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101391079A (zh) * | 2008-11-06 | 2009-03-25 | 徐朝阳 | 治疗脂肪肝的中药 |
CN102205088A (zh) * | 2011-05-03 | 2011-10-05 | 刘晓娜 | 一种治疗脂肪肝的中药胶囊 |
CN105412406A (zh) * | 2016-01-14 | 2016-03-23 | 青岛友诚高新技术有限公司 | 一种降低血液粘稠度的中药组合物及其制备方法 |
-
2016
- 2016-04-29 CN CN201610294414.9A patent/CN105749181A/zh not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101391079A (zh) * | 2008-11-06 | 2009-03-25 | 徐朝阳 | 治疗脂肪肝的中药 |
CN102205088A (zh) * | 2011-05-03 | 2011-10-05 | 刘晓娜 | 一种治疗脂肪肝的中药胶囊 |
CN105412406A (zh) * | 2016-01-14 | 2016-03-23 | 青岛友诚高新技术有限公司 | 一种降低血液粘稠度的中药组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
段富津: "《方剂学》", 30 June 1995, 上海科学技术出版社 * |
王强虎等: "《脂肪肝绿色疗法》", 30 June 2015, 人民军医出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106334046A (zh) * | 2016-08-04 | 2017-01-18 | 青岛友诚高新技术有限公司 | 一种治疗鼻炎的中药组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101019984B (zh) | 一种治疗便秘的中药制剂 | |
CN105749179A (zh) | 治疗代谢综合征的中药组合物 | |
CN101019985B (zh) | 一种治疗便秘的中成药 | |
CN105434648A (zh) | 一种治疗急性乳腺炎的中药组合物及其制备方法 | |
CN101590168B (zh) | 一种用于治疗痛风的中药组合物及其制备方法 | |
CN102228550A (zh) | 一种治疗肠易激综合征的药物组合物 | |
CN104147536A (zh) | 一种治疗痔疮的药物组合物及其制备方法 | |
CN105749181A (zh) | 一种治疗脂肪肝的中药组合物及其制备方法 | |
CN101590166B (zh) | 一种用于治疗痛风的中药组合物及其制备方法 | |
CN105079463A (zh) | 一种治疗心血管疾病的中药制剂及其制备方法 | |
CN104274720A (zh) | 一种排石通淋的中药组合物 | |
CN106166267A (zh) | 一种治疗胆结石的中药组合物及其制备方法 | |
CN103386101A (zh) | 一种治疗非特异性膀胱炎的中药制剂及其制备方法 | |
CN101028421B (zh) | 一种治疗慢性肾衰的中成药 | |
CN105477384A (zh) | 一种降低血压的中药组合物及其制备方法 | |
CN106266427A (zh) | 一种治疗肾病的中药药酒及其制备方法 | |
CN105726981A (zh) | 一种治疗肺结核的中药组合物及其制备方法 | |
CN106166214A (zh) | 一种治疗扁桃体炎的中药组合物及其制备方法 | |
CN106361874A (zh) | 治疗游走性痛风瑶药复方半荷风制剂及其制备方法 | |
CN106138848A (zh) | 一种治疗肾炎的中药胶囊剂及其制备方法 | |
CN105477246A (zh) | 一种治疗痰湿型乳腺增生的中药组合物及其制备方法 | |
CN100450537C (zh) | 一种治疗前列腺增生的中药制剂 | |
CN105169175A (zh) | 一种治疗慢性胃炎的中药制剂及其制备方法 | |
CN106309846A (zh) | 一种治疗胆囊炎的中药组合物及其制备方法 | |
CN104127754A (zh) | 一种治疗风湿病的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160713 |